跳至主要内容
临床试验/NCT03410069
NCT03410069已完成不适用

Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients: a Pilot Clinical Study To Evaluate the aPplicability and the Safety of Urethral Perfusion Measurement With the IKORUS System

Advanced Perfusion Diagnostics7 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年8月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
7
主要终点
Incidence of complications

研究概览

简要总结

Circulatory shock is defined as an imbalance between oxygen supply and/or impaired oxygen use to maintain organ function. With growing evidence of lack of correlation between macro- and micro-circulation, use of "Whole Body" markers such as blood pressure (BP) or Lactates are often insufficient to assess the severity of the oxygen debt and/or tissue hypoperfusion. Thus, an approach incorporating tissue-perfusion based endpoints would represent a significant step up to guide optimal resuscitation of critically-ill patients and to reduce complications in high-risk surgery.

Current monitoring techniques, that complement systemic hemodynamics by focusing on regional perfusion, still lack the required user-friendliness and/or clinical relevance to be routinely used at bedside. Therefore, assessment of the adequacy of tissue perfusion and oxygenation is suboptimal, and implementation of the above-mentioned approaches of resuscitation is still a challenge.

Urethral perfusion is likely to be early and significantly impaired during low-flow states and thus represents a good "candidate" as a surrogate site to assess the perfusion of visceral organs. Besides, urethral mucosa can be investigated in a less invasive and simpler manner than "deeper" organs. Nowadays, no practical methods or devices are available to monitor perfusion in the pelvic area. Thus, recent development of a new monitoring device of urethral perfusion could fill this need and enable enhanced management of patients in Intensive Care Units (ICU) and Operating Rooms (OR).

The device consists of a modified Foley catheter equipped with a photoplethysmographic sensor: the IKORUS UP probe.

The probe will be used by intensivists or anesthesiologists on high-risk surgical patients, i.e. patients with comorbidities undergoing major vascular, thoracic and/or abdominal surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or more,
  • Male or female,
  • High-Risk surgical patient,
  • Life expectancy expected to exceed 72 hours,
  • Willing to participate and signed informed consent,
  • Affiliation to the French social security system.
  • Non inclusion criteria:
  • Pregnant or lactating woman,
  • History of recent urological surgery (bladder surgery, prostate surgery...),
  • Known stricture or "impossible insertion" last hospitalization,
  • Traumatic injury to the lower urinary tract,
  • History of radiotherapy of pelvic or genital area,
  • Genital malformation (Hypospadias...).

排除标准

  • 未提供

研究组 & 干预措施

IKORUS UP

Experimental

干预措施: IKORUS UP system (Device)

结局指标

主要结局

Incidence of complications

时间窗: 28 days

Complications rate: Injury during insertion; Bleeding; Infection; Pain; Discomfort.

次要结局

  • Signal acquisition(28 days)
  • Evolution of SpO2(28 days)
  • Evolution of SVO2(28 days)
  • Evolution of central venous pressure(28 days)
  • Evolution of mean arterial pressure(28 days)
  • Evolution of catecholamine infusions levels(28 days)
  • Effect of the position of the sensor(28 days)
  • Evolution of lactates dosages(28 days)
  • Evolution of cardiac outputs(28 days)
  • Applicability of the procedure(28 days)
  • Quality of the signal(28 days)
  • Rate of resuscitation events(28 days)

研究者

发起方
Advanced Perfusion Diagnostics
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验